These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 9443088)
1. Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma. Kim YS; Chi SG; Kim YW; Park YK; Yoon C J Korean Med Sci; 1997 Dec; 12(6):505-13. PubMed ID: 9443088 [TBL] [Abstract][Full Text] [Related]
2. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Friedrichs K; Franke F; Lisboa BW; Kügler G; Gille I; Terpe HJ; Hölzel F; Maass H; Günthert U Cancer Res; 1995 Nov; 55(22):5424-33. PubMed ID: 7585612 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation. Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108 [TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of CD44 pre-mRNA in human colorectal tumors. Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991 [TBL] [Abstract][Full Text] [Related]
5. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811 [TBL] [Abstract][Full Text] [Related]
6. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues. Higashikawa K; Yokozaki H; Ue T; Taniyama K; Ishikawa T; Tarin D; Tahara E Int J Cancer; 1996 Mar; 66(1):11-7. PubMed ID: 8608952 [TBL] [Abstract][Full Text] [Related]
8. CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Rodriguez C; Monges G; Rouanet P; Dutrillaux B; Lefrançois D; Theillet C Int J Cancer; 1995 Oct; 64(5):347-54. PubMed ID: 7591309 [TBL] [Abstract][Full Text] [Related]
9. Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors. Goodison S; Yoshida K; Sugino T; Woodman A; Gorham H; Bolodeoku J; Kaufmann M; Tarin D Cancer Res; 1997 Aug; 57(15):3140-4. PubMed ID: 9242440 [TBL] [Abstract][Full Text] [Related]
10. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis. Givehchian M; Woerner SM; Lacroix J; Zöller M; Drings P; Becker H; Kayser K; Ridder R; von Knebel Doeberitz M Oncogene; 1996 Mar; 12(5):1137-44. PubMed ID: 8649806 [TBL] [Abstract][Full Text] [Related]
11. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas. Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634 [TBL] [Abstract][Full Text] [Related]
12. Trans-acting factors regulate the expression of CD44 splice variants. Konig H; Moll J; Ponta H; Herrlich P EMBO J; 1996 Aug; 15(15):4030-9. PubMed ID: 8670907 [TBL] [Abstract][Full Text] [Related]
13. Different CD44 splicing patterns define prognostic subgroups in multiple myeloma. Stauder R; Van Driel M; Schwärzler C; Thaler J; Lokhorst HM; Kreuser ED; Bloem AC; Günthert U; Eisterer W Blood; 1996 Oct; 88(8):3101-8. PubMed ID: 8874209 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression. Hayes GM; Dougherty ST; Davis PD; Dougherty GJ Cancer Gene Ther; 2004 Dec; 11(12):797-807. PubMed ID: 15359288 [TBL] [Abstract][Full Text] [Related]
15. Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases. Frank S; Rihs HP; Stöcker W; Müller J; Dumont B; Baur X; Schackert HK; Schackert G Biochem Biophys Res Commun; 1996 May; 222(3):794-801. PubMed ID: 8651925 [TBL] [Abstract][Full Text] [Related]
16. Clear cell carcinoma of the ovary: characterization of its CD44 isoform repertoire. Sancho-Torres I; Mesonero C; Miller Watelet JL; Gibbon D; Rodríguez-Rodríguez L Gynecol Oncol; 2000 Nov; 79(2):187-95. PubMed ID: 11063642 [TBL] [Abstract][Full Text] [Related]
17. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Ermak G; Jennings T; Robinson L; Ross JS; Figge J Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758 [TBL] [Abstract][Full Text] [Related]
18. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them. Hudson DL; Speight PM; Watt FM Int J Cancer; 1996 May; 66(4):457-63. PubMed ID: 8635860 [TBL] [Abstract][Full Text] [Related]